WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-13 Cr | ₹1.01 Cr | ₹-15 Cr | ₹-44 Cr | ₹130 Cr |
What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-13 Cr |
| Mar2025 | ₹1.01 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹-44 Cr |
| Mar2022 | ₹130 Cr |
How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-13 Cr | Negative | |
| Mar2025 | ₹1.01 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹-44 Cr | Negative | |
| Mar2022 | ₹130 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,730.1 Cr | 1.7% | 2.6% | -4.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 1.7% |
2.6% |
-4.5% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses